2021
DOI: 10.1007/s12016-021-08860-7
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorders (CVID) in the New Zealand CVID Cohort Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 45 publications
1
7
0
Order By: Relevance
“…A similar outcome was noted in the New Zealand CVID Study (NZCS) ( 48 , 49 ). Most patients meeting criteria for CVID had excellent responses to tetanus toxoid and HIB.…”
Section: Cvid As a Model Of Vaccine Challenge Responses In Immunocompromised Personssupporting
confidence: 76%
“…A similar outcome was noted in the New Zealand CVID Study (NZCS) ( 48 , 49 ). Most patients meeting criteria for CVID had excellent responses to tetanus toxoid and HIB.…”
Section: Cvid As a Model Of Vaccine Challenge Responses In Immunocompromised Personssupporting
confidence: 76%
“…9,10 Other researchers have compared those criteria and added guidelines for their proper interpretation. 13,23,24 In our settings, the ESID registry working definition for CVID is a powerful tool to characterize the hipogammaglobulinemic patients. 9 Most of the patients included here fulfilled the clinical criteria defined by ESID and also exhibited decreased serum IgG and IgA levels.…”
Section: Discussionmentioning
confidence: 99%
“…This was also problematic in other studies. 24 However, the international consensus for CVID diagnosis establishes that the repeated Ig measurement can be disregarded if either the IgG levels are below 100-300 mg/dL, depending on age, or if there are clinical considerations to start the Ig replacement as quickly as possible. 13 Currently, we performed the two required Ig measurements and a serum protein electrophoresis to confirm the hypogammaglobulinemia in the CVID suspicious patients who have no indication to speed up the replacement SCIG/IVIG therapy.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations